^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    COMPANY:
    Panagene

    i
    Other names: Panagene | PANAGENE | PANAGENE Inc. | PANAGENE Inc
    Related tests:
    Evidence

    News

    over1year
    Panagene teams up with Yuhan to develop companion diagnostic for Leclaza (Korea Biomedical Review)
    "Panagene said on Monday it signed a contract with Yuhan Corp. to jointly develop the original companion diagnostic (CDx), called PANAMutyper R EGFR, for Yuhan’s lung cancer drug Leclaza (lazertinib)....A Yuhan official said that pursuing clinical trials and licensing of PANAMutyper R EGFR as the original companion diagnosis of Leclaza together with Panagene, a leader in domestic companion diagnosis, will be a new milestone in the development of CDx in Korea."
    Licensing / partnership
    |
    PANAMutyper™ R EGFR
    |
    Leclaza (lazertinib)